International Regulators Plan Roadmap For Collaborative RWE Studies
Executive Summary
Experiences during the COVID-19 pandemic are expected to help identify future opportunities for regulatory cooperation on real-world evidence and avoid divergent decision-making for products including advanced therapies and personalized medicines.